Lars Blomquist
Impact in
- Genetics top 2%
- Inflammatory Bowel Disease
- Gastroenterology top 5%
- Gastrointestinal motility and disorders
Papers in
-
- Gastrointestinal motility and disorders 9
- Genetics 9
- Inflammatory Bowel Disease 9
- Co-authors
- Per M. Hellström (6 shared papers)MOGENS VILIEN (4 shared papers)Erik Hertervig (4 shared papers)Ingalill Friis–Liby (4 shared papers)Anders Magnuson (4 shared papers)Hans Verbaan (4 shared papers)Per Karlén (4 shared papers)Christer Grännö (4 shared papers)
In The Last Decade
Lars Blomquist
38 papers receiving 1.6k citations
Lars Blomquist's Hit Papers
Peers
Comparison fields: 5 of 82
- Genetics 1.1k
- Gastroenterology 125
- Hepatology 61
- Pharmaceutical Science 38
- Neurology 24
Countries citing papers authored by Lars Blomquist
This map shows the geographic impact of Lars Blomquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Blomquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Blomquist more than expected).
Fields of papers citing papers by Lars Blomquist
This network shows the impact of papers produced by Lars Blomquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Blomquist. The network helps show where Lars Blomquist may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Blomquist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study Hit paper breakdown → | 2005 | 878 |
| 2 | 2010 | 153 | |
| 3 | 1995 | 77 | |
| 4 | 1998 | 56 | |
| 5 | 2011 | 53 | |
| 6 | 1984 | 49 | |
| 7 | 1977 | 36 | |
| 8 | 1993 | 32 | |
| 9 | 2013 | 31 | |
| 10 | 2002 | 30 | |
| 11 | 2003 | 30 | |
| 12 | 1966 | 22 | |
| 13 | 1997 | 21 | |
| 14 | 1993 | 18 | |
| 15 | 1982 | 17 | |
| 16 | 1995 | 17 | |
| 17 | 2001 | 16 | |
| 18 | 1987 | 15 | |
| 19 | A 2-year follow-up of the swedish-danish Infliximab/Placebo trial in steroid resistant acute ulcerative colitis | 2007 | 15 |
| 20 | 1975 | 12 |
About Lars Blomquist
Lars Blomquist is a scholar working on Gastroenterology, Genetics, Radiology, Nuclear Medicine and Imaging, Toxicology and Cellular and Molecular Neuroscience, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Gastrointestinal motility and disorders (9 papers), Inflammatory Bowel Disease (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Pesticide Exposure and Toxicity (3 papers), Insect Pest Control Strategies (3 papers), Neuropeptides and Animal Physiology (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Bone health and treatments (2 papers). The work is most often cited by research in Genetics (1.1k citations), Gastroenterology (125 citations), Hepatology (61 citations), Pharmaceutical Science (38 citations) and Neurology (24 citations). Lars Blomquist has collaborated with scholars based in Sweden, Hungary and Norway. Frequent co-authors include Per M. Hellström, MOGENS VILIEN, Erik Hertervig, Ingalill Friis–Liby, Anders Magnuson, Hans Verbaan, Per Karlén, Christer Grännö, Magnus Ström and Åke Danielsson. Their work appears in journals such as Scandinavian Journal of Gastroenterology, Gut, European Journal of Gastroenterology & Hepatology, Gastroenterology and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.